MX2008002012A - Emulsion de tipo aceite en agua para la aplicacion topica en dermatologia. - Google Patents

Emulsion de tipo aceite en agua para la aplicacion topica en dermatologia.

Info

Publication number
MX2008002012A
MX2008002012A MX2008002012A MX2008002012A MX2008002012A MX 2008002012 A MX2008002012 A MX 2008002012A MX 2008002012 A MX2008002012 A MX 2008002012A MX 2008002012 A MX2008002012 A MX 2008002012A MX 2008002012 A MX2008002012 A MX 2008002012A
Authority
MX
Mexico
Prior art keywords
oil
water
type emulsion
dermatology
topical application
Prior art date
Application number
MX2008002012A
Other languages
English (en)
Inventor
Sandrine Segura-Orsoni
Original Assignee
Galderma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Sa filed Critical Galderma Sa
Publication of MX2008002012A publication Critical patent/MX2008002012A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invencion se refiere a una nueva composicion topica bajo la forma de emulsion de tipo aceite en agua, de alta proporcion de fase aceitosa en fase interna, que tiene las propiedades oclusivas y emolientes de un unguento sin presentar los inconvenientes de sensacion grasosa, favoreciendo las propiedades terapeuticas del agente biologicamente activo presente en la composicion.
MX2008002012A 2005-08-11 2006-08-09 Emulsion de tipo aceite en agua para la aplicacion topica en dermatologia. MX2008002012A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0508524A FR2889662B1 (fr) 2005-08-11 2005-08-11 Emulsion de type huile-dans-eau pour application topique en dermatologie
PCT/FR2006/001930 WO2007020349A1 (fr) 2005-08-11 2006-08-09 Émulsion de type huile-dans-eau pour application topique en dermatologie

Publications (1)

Publication Number Publication Date
MX2008002012A true MX2008002012A (es) 2008-03-25

Family

ID=36273334

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008002012A MX2008002012A (es) 2005-08-11 2006-08-09 Emulsion de tipo aceite en agua para la aplicacion topica en dermatologia.

Country Status (12)

Country Link
US (1) US20080207570A1 (es)
EP (1) EP1915133A1 (es)
JP (1) JP2009504619A (es)
KR (1) KR20080033389A (es)
CN (1) CN101304729A (es)
AU (1) AU2006281346B2 (es)
BR (1) BRPI0616520A2 (es)
CA (1) CA2617963A1 (es)
FR (1) FR2889662B1 (es)
MX (1) MX2008002012A (es)
RU (2) RU2008108973A (es)
WO (1) WO2007020349A1 (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
ES2447301T3 (es) 2005-06-01 2014-03-11 Glaxosmithkline Intellectual Property Development Limited Formulación vitamínica
FR2892936A1 (fr) * 2005-11-10 2007-05-11 Galderma Res & Dev Composition pharmaceutique ou cosmetique, et procede de solubilisation mixte pour preparer la composition.
HUE028588T2 (hu) 2005-12-13 2016-12-28 Incyte Holdings Corp Heteroaril-szubsztituált pirrolo[2,3-b]piridinek és pirrolo[2,3-b]pirimidinek mint Janus-kináz inhibitorok
FR2898499B1 (fr) * 2006-03-15 2008-11-28 Galderma Sa Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
FR2898498B1 (fr) * 2006-03-15 2008-11-28 Galderma Sa Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
FR2915682B1 (fr) * 2007-05-04 2009-07-03 Galderma Res & Dev Compositions depigmentantes dermatologiques et cosmetiques, leurs procedes de preparation, et leurs utilisations
EP2740731B1 (en) 2007-06-13 2016-03-23 Incyte Holdings Corporation Crystalline salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
EP2008651A1 (en) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
US20100249060A1 (en) * 2009-02-23 2010-09-30 Smith Jan G Topical formulation of low level clobetasol propionate for treating disorders of the skin and mucous membranes
WO2010115164A1 (en) * 2009-04-03 2010-10-07 Medicis Pharmaceutical Corporation Topical compositions
NZ596479A (en) 2009-05-22 2014-01-31 Incyte Corp N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
BRPI1012108B8 (pt) 2009-05-22 2021-05-25 Incyte Corp composto 3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il]octa no- ou heptano-nitrila, sua composição, seus usos e processo para preparar um sal de ácido fosfórico
US9364485B2 (en) 2009-08-31 2016-06-14 Dr. Reddy's Laboratories Ltd. Topical formulations comprising a steroid
TW201113285A (en) 2009-09-01 2011-04-16 Incyte Corp Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
US20110212035A1 (en) * 2010-02-26 2011-09-01 Collegium Pharmaceutical, Inc. Emollient foams for treatment of dermatoses
CA2792508C (en) 2010-03-10 2018-01-16 Incyte Corporation Piperidin-4-yl azetidine derivatives as jak1 inhibitors
EA202091303A3 (ru) 2010-05-21 2021-05-31 Инсайт Холдингс Корпорейшн Композиция ингибитора jak для местного применения
CA2818542A1 (en) 2010-11-19 2012-05-24 Incyte Corporation Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
US9610245B2 (en) 2011-03-14 2017-04-04 Drug Delivery Solutions Limited Ophthalmic composition
US8691807B2 (en) 2011-06-20 2014-04-08 Incyte Corporation Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors
TW201313721A (zh) 2011-08-18 2013-04-01 Incyte Corp 作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物
UA111854C2 (uk) 2011-09-07 2016-06-24 Інсайт Холдінгс Корпорейшн Способи і проміжні сполуки для отримання інгібіторів jak
JP5909941B2 (ja) * 2011-09-08 2016-04-27 大正製薬株式会社 ステロイド性抗炎症薬含有外用剤
TW201406761A (zh) 2012-05-18 2014-02-16 Incyte Corp 做爲ｊａｋ抑制劑之哌啶基環丁基取代之吡咯并吡啶及吡咯并嘧啶衍生物
KR102242077B1 (ko) 2012-11-15 2021-04-20 인사이트 홀딩스 코포레이션 룩솔리티니브의 서방성 제형
EP3489239B1 (en) 2013-03-06 2021-09-15 Incyte Holdings Corporation Processes and intermediates for making a jak inhibitor
CA2908041C (en) * 2013-04-04 2018-05-01 Hyundai Pharm Co., Ltd. Composition for external use preparation with improved transdermal permeability
HK1223300A1 (zh) * 2013-06-03 2017-07-28 Tolmar, Inc. 皮质类固醇组合物
MX376856B (es) 2013-08-07 2025-03-07 Incyte Holdings Corp Formas de dosificacion de liberacion prolongada para un inhibidor de jak 1 (cinasa de janus 1).
US20160184431A1 (en) * 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
WO2015184305A1 (en) 2014-05-30 2015-12-03 Incyte Corporation TREATMENT OF CHRONIC NEUTROPHILIC LEUKEMIA (CNL) AND ATYPICAL CHRONIC MYELOID LEUKEMIA (aCML) BY INHIBITORS OF JAK1
DE102014010875A1 (de) * 2014-07-25 2016-01-28 Basf Se Transparente Textilpflegemittel
WO2017037663A1 (en) 2015-09-02 2017-03-09 Cadila Healthcare Limited Topical compositions comprising corticosteroids
KR20220082095A (ko) 2015-10-30 2022-06-16 팀버 파마슈티칼스 엘엘씨 이소트레티노인 제형 및 이의 용도 및 사용 방법
SG11201912393XA (en) * 2017-06-23 2020-01-30 Salvat Lab Sa An oil-in-water nanoemulsion composition of clobetasol
TW201924683A (zh) 2017-12-08 2019-07-01 美商英塞特公司 用於治療骨髓增生性贅瘤的低劑量組合療法
MD3746429T2 (ro) 2018-01-30 2022-08-31 Incyte Corp Procedee pentru prepararea de (1-(3-fluoro-2-(trifluorometil)izonicotinil)piperidin-4-onă)
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
KR20260080448A (ko) 2018-03-30 2026-06-02 인사이트 코포레이션 Jak 억제제를 사용하는 화농성 한선염의 치료
AU2019472201B2 (en) * 2019-11-01 2024-05-02 Colgate-Palmolive Company Stable low pH personal care compositions and methods for the same
US11833155B2 (en) 2020-06-03 2023-12-05 Incyte Corporation Combination therapy for treatment of myeloproliferative neoplasms
CN113925800B (zh) * 2021-11-03 2024-09-13 时垠(上海)生物科技有限公司 提高单硬脂酸甘油酯乳化体系乳化能力的方法
KR102831554B1 (ko) * 2022-10-24 2025-07-09 주식회사 코리아나화장품 피부투과촉진 복합물을 포함하는 액정 겔 화장료 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837378A (en) * 1986-01-15 1989-06-06 Curatek Pharmaceuticals, Inc. Topical metronidazole formulations and therapeutic uses thereof
JP3454385B2 (ja) * 1993-10-15 2003-10-06 啓次郎 佐藤 Ｏ／ｗ型皮膚用クリームの製造方法
US5853732A (en) * 1996-11-12 1998-12-29 Pharmacia & Upjohn Company Pharmaceutical compositions containing kukui nut oil
US5972993A (en) * 1998-03-20 1999-10-26 Avon Products, Inc. Composition and method for treating rosacea and sensitive skin with free radical scavengers
FR2787025B1 (fr) * 1998-12-14 2002-10-11 Oreal Composition sous forme d'emulsion h/e a forte teneur en cire et ses utilisations dans les domaines cosmetique et dermatologique
US6403654B1 (en) * 2000-04-13 2002-06-11 Mariana De Oliveira Compositions for and method of treatment for psoriasis
US6699464B1 (en) * 2001-07-30 2004-03-02 Stiefel Laboratories, Inc. Compositions for treatment of hyperpigmentation and methods for making and using such compositions
FR2833841B1 (fr) * 2001-12-21 2005-07-22 Galderma Res & Dev Gel comprenant au moins un retinoide et du peroxyde de benzoyle
US20030129208A1 (en) * 2002-01-07 2003-07-10 Alberts David S. Topical application of alpha-DFMO and anti-inflammatory drug for treatment of actinic keratoses
AU2003252187A1 (en) * 2002-05-15 2003-12-02 Engelbrecht, Edna Topical composition for the treatment of inflammatory conditions of the skin
KR20050109562A (ko) * 2003-03-13 2005-11-21 쓰리엠 이노베이티브 프로퍼티즈 컴파니 피부의 질을 개선시키는 방법
TWI397427B (zh) * 2004-08-31 2013-06-01 史迪費爾研究澳洲股份有限公司 微乳化液、次微米乳化液的方法及組成物

Also Published As

Publication number Publication date
RU2008108973A (ru) 2009-09-20
WO2007020349A1 (fr) 2007-02-22
CA2617963A1 (fr) 2007-02-22
EP1915133A1 (fr) 2008-04-30
JP2009504619A (ja) 2009-02-05
AU2006281346A1 (en) 2007-02-22
US20080207570A1 (en) 2008-08-28
FR2889662A1 (fr) 2007-02-16
CN101304729A (zh) 2008-11-12
KR20080033389A (ko) 2008-04-16
FR2889662B1 (fr) 2011-01-14
BRPI0616520A2 (pt) 2011-06-21
RU2011125550A (ru) 2012-12-27
AU2006281346B2 (en) 2012-03-29

Similar Documents

Publication Publication Date Title
CY1118454T1 (el) Πρωτοτυποι αναστολεις πυρρολιου της αναγωγασης s-νιτροζογλουταθειονης ως θεραπευτικοι παραγοντες
BRPI0508561A (pt) 3-'4-heterociclil-1,2,3-triazol-1-il-n-aril-benzamidas como inibidores da produção de citocinas para o tratamento de doenças inflamatórias crÈnicas
GB2394662A (en) Topical composition for treating pain
BRPI0516483A (pt) preparo e uso de derivados de ácido bifenil-4-il-carbonilamino para o tratamento de obesidade
MX2010002592A (es) Composicion farmaceutica topica para la combinacion de acido fusidico y corticoesteroides.
TW200700059A (en) A topical composition and its uses
EA201291310A1 (ru) Композиция ингибитора jak для местного применения
EA201171079A1 (ru) Пенообразующая композиция для местного применения
EA200970337A1 (ru) Ингибиторы котранспортера натрий-глюкозы 2 и способы их применения
BRPI0518904A2 (pt) formulaÇÕes de nepafenac tàpicas
WO2007046102A3 (en) Methods for the treatment of hyperhidrosis
WO2007109230A3 (en) Nutrient compositions for the treatment and prevention of inflammation and disorders associated therewith
CR10305A (es) "derivados sustituidos de cromanol y su uso.
WO2008061724A3 (en) Compositions comprising carnosic acid 12-methylether
EA200901289A1 (ru) Композиции и способы для противовосполительного лечения
BRPI0911469A8 (pt) Inibidores de gm-csf e il-17 para terapia
WO2008079610A3 (en) Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
WO2010003568A8 (en) Topical composition for the treatment of actinic keratosis
WO2007046097A3 (en) Topical compositions for the treatment of depilation-induced skin irritation or prevention thereof
BRPI0715361B8 (pt) uso de polietileno glicol em inflamação relacionada com doenças ou distúrbios tópicos e cicatrização de ferimento
WO2007028022A3 (en) Novel compounds as p2x7 modulators and uses thereof
WO2009156675A3 (fr) Nouvelles compositions dépigmentantes sous forme d'une composition anhydre sans vaseline et sans élastomère comprenant un dérivé phénolique solubilisé et un rétinoïde
TW200745122A (en) New compounds I
MX2007002525A (es) Compuestos de difeniletileno y usos de los mismos.
WO2008070602A3 (en) Topical pharmaceutical composition

Legal Events

Date Code Title Description
FG Grant or registration